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Micro-anatomical changes in the aorta, pulmonary trunk, and left ventricle of
Wistar rats were studied after the administration of streptozotocin. Twenty
adult Rattus norvegicus were randomly assigned into two groups (control and
diabetic) of ten rats each. Diabetes mellitus was experimentally induced in the
diabetic group of rats by daily intra-peritoneal administration of multiple doses
of 40 mg/kg streptozotocin dissolved in 0.1 M sodium citrate buffer for five
consecutive days. The control group was given the equivalent volume of citrate
buffer. The animals were monitored for four weeks after streptozotocin ad-
ministration. Post sacrifice, the left ventricle, aorta, and pulmonary trunk were
excised, weighed, and fixed by immersion in 10% formol saline. The tissues
were processed for paraffin embedding, and sections of 6 µm thickness were
produced and stained with H & E for general histological observations, and
Verhoeff-van Gieson elastic fibre stain to demonstrate elastic fibres in these
cardiovascular structures. The data obtained were analyzed with descriptive
and inferential statistics. Histopathological and morphometric examinations of
the stained sections showed a significant increase in the thickness of the tunica
intima of aorta (t = –7.49; df = 9; p < 0.05) and pulmonary trunk (t = –10.81;
df = 9; p < 0.05) in diabetic rats (14.59 ± 1.189 mm and 11.307 ± 0.863 mm,
respectively) when compared to that of the control group (3.62 ± 0.353 mm
and 3.22 ± 0.244 mm, respectively). In addition, the distribution of elastic and
collagen fibres was sparse in the hearts of the diabetic group when compared
to that of the control group. The findings of this study demonstrated that dia-
betes mellitus might cause some alterations in the microanatomy of cardiovas-
cular structures. (Folia Morphol 2009; 68, 4: 207–214)
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INTRODUCTION
Diabetes mellitus is a complex metabolic disease
caused by impairment of insulin signalling, path-
ways, and the defect usually results from pancre-
atic beta-cell deficiency and/or a deficiency of insulin
[13, 16]. This disease causes many chronic compli-
cations such as vascular disease, retinopathy, neur-
opathy, kidney disease, and heart disease. Cardio-
vascular disease is one of the major causes of death
in diabetic patients [1, 38]. Since heart is one of the
most important target tissues of diabetes, the in-
creased rate of mortality and morbidity of these
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patients has been attributed to diabetic cardiomy-
opathy [10, 12]. Furthermore, growing evidence
showing impaired diastolic performance followed
by depressed systolic function in diabetic patients
supports this hypothesis. Although it has been re-
cognized for many years that diabetes mellitus is
associated with cardiac dysfunction caused by cardio-
myopathy without significant coronary artery dis-
ease, the pathogenesis of diabetic cardiomyopathy
remains unclear.
Increased production of reactive oxygen species
(ROS), as well as nitrogen species, is a well-known
phenomenon in hyperglycaemic conditions. Al-
though the aetiology of the hyperglycaemia-induced
cellular damage has not yet been clarified, free rad-
icals and oxidative stress are thought to be the con-
tributory factors underlying these abnormalities. The
auto oxidation of glucose, the formation of glyca-
tion end products and the activation of NADPH
oxidase have been suggested as possible sources of
the augmented oxidative stress in diabetes. Thus,
elevated free radical levels activate various subcel-
lular signal transduction pathways, including abnor-
mal gene expression, which may cause myocardial
cell death. Related with these suggestions, increased
production of thiobarbituric acid-reactive substances
(TBARS), which is an index of oxidative stress and
lipid peroxidation, has been reported in diabetic
hearts [2, 17, 18, 34].
Streptozotocin (STZ), an antibiotic produced by
Streptomyces achromogenes, possesses a pancre-
atic beta-cell cytotoxic effect [36]. Streptozotocin has
been widely used to induce diabetes mellitus in
a variety of animals. This well-established model is
characterized by insulin deficiency associated with
insulin resistance [3]. It was reported that a single
intravenous injection of STZ could cause increased
plasma glucose levels, decrease in body weight, and
17% mortality in rats [3]. STZ causes degeneration
and necrosis of pancreatic beta cells [27, 35]. Al-
though the mechanism of the beta cell cytotoxic
action of STZ is not fully understood, experimental
evidence has demonstrated that some of its delete-
rious effects are attributable to induction of meta-
bolic processes which lead to an increase in the gen-
eration of ROS [6]. Apart from production of ROS,
STZ also inhibits free radical scavenger-enzymes [20].
The superoxide radical has been implicated in lipid
peroxidation, DNA damage, and sulfhydryl oxida-
tion [26, 33].
Cardiovascular disorder is implicated as a major
cause of death in diabetic patients, thus this study
aimed at investigating the microarchitectural aspect
of the cardiovascular disorder following induction
of diabetes under laboratory conditions.
MATERIAL AND METHODS
Care and management of animals
Twenty healthy adult male Wistar rats (Rattus
norvegicus), weighing between 150 g and 250 g,
were used for the experiment. They were kept in in-
dividual cages under natural light and dark cycles
at room temperature. They were maintained on stan-
dard rat pellets (Ladokun feeds, Ibadan, Nigeria) and
water given ad libitum. The animals were randomly
assigned into two groups (control and diabetic) of
ten rats each. There was a pre-experimental period
of four weeks, during which the body weight, blood
glucose level, and serum lipid profiles were moni-
tored in the animals. The rats received humane care
according to the criteria outlined in the “Guide for
the Care and Use of Laboratory Animals” prepared
by the National Academy of Sciences and published
by the National Institute of Health [28].
Experimental induction of diabetes
Diabetes mellitus was induced in the diabetic
group of rats by intraperitoneal administration of
multiple low doses of streptozotocin (Sigma, St.
Louis, USA) (40 mg/kg body weight) dissolved in
freshly prepared 0.1 M sodium citrate buffer (pH 6.3)
for five days, while the animals in the control group
were given the equivalent volume of citrate buffer
intraperitoneally. The rats were fasted overnight
before STZ administration. The daily body weight
and the weekly blood glucose level were monitored
in the animals for the next four weeks.
Determination of body weight and
blood glucose level
The body weight of the animals was measured
using a top loader weighing balance. Blood sam-
ples were obtained from the tail vein of the animals,
and their fasting blood glucose level was determined
in mmol/L using a digital glucometer (Accu-chek®
Advantage, Roche Diagnostic, Germany). The ani-
mals were fasted for a period of 16 hours before
their blood glucose level was measured.
Surgical procedures
A mid-line incision was made in the thoracic wall
of the rats under slight anaesthesia using pento-
barbital (6.4 mg/100 g body weight i.m.), and the
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heart, aorta, and pulmonary trunk were removed
and weighed on a top loader sensitive balance (Met-
tler Toledo, Germany). The aorta was isolated from
the systemic circulatory tract by cutting it through
its commencement at the ascending aorta (as it
comes out of the left ventricle) and its terminal end
as it bifurcates into two common iliac arteries at
the level of the L1 Vertebra, while the pulmonary
trunk was isolated from the pulmonary circulatory
tract by cutting through its commencement as it
comes out of the right ventricle (RV) and its termi-
nus as it bifurcates into the right and left pulmo-
nary arteries. The left ventricle (LV) was isolated from
the remaining part of the heart through incisions
made in the coronary sulcus and interventricular
groove and was weighed. The relative heart weight
and the relative left ventricular weight was calculat-
ed as follows.
Histological procedure
The excised tissues (LV, ascending aorta, and
pulmonary trunk) were fixed in 10% formol saline
by total immersion for 48 hours and were processed
via the paraffin wax embedding method of Drury
and Wallington [9]. Paraffin-embedded sections
were cut at 6 µm and stained with (a) haematoxylin
and eosin (HE) for histoarchitectural examination of
the tissues and (b) Verhoeff-Van Gieson stain for
demonstration of elastic and collagen fibres. The
sections were examined under a Carl Zeiss research
microscope (Axioskope 40, Germany) with a digital
camera attached. Digital photomicrographs of the
pancreatic sections were taken at various magnifi-
cations.
Histomorphometric analysis
All morphometric studies were carried out on an
Olympus research microscope (Olympus WF10X,
Japan) with a linear scale-ocular micrometer insert-
ed into the eyepiece. The ocular micrometer was
calibrated with a 1 mm stage micrometer (Graticles
Tonbridge, Kent, England). Forty-eight histological
stained sections were used for morphometric ana-
lysis; eight sections each of the aorta, pulmonary
trunk, and left ventricle of the control and diabetic
groups of the rats were examined at different mag-
nifications to estimate the (i) diameter of the lumen,
(ii) thickness of the entire wall, and (ii) thickness of
the each of the tunica intima, media, and adventi-
tia. With an ocular micrometer and a graticule of
a calibrated linear scale, the major axis (a) and minor
axis (b) at right angles to the major axis of the lumen of
each of the aorta, pulmonary trunk, and left ventricle
were measured at 40¥ magnification. The lumen dia-
meter of the sections (Di) was calculated from the
equation Di =          [37].  The wall to lumen ratio of the
vessels was calculaed as                                   .
Using a calibrated ocular micrometer, the thick-
ness of the entire wall of each of the aorta, pulmo-
nary trunk, and left ventricle was measured in mm at
400¥ magnification while the thickness of each of
the tunica intima, media, and adventitia of the aor-
ta and pulmonary trunk was measured at 1000¥
magnification.
Statistical analysis
The data were analysed using descriptive and
inferential statistics. All values are presented as mean
± standard error of mean (SEM) for ten rats in each
of the two groups of rats. The significance of differ-
ence in the means of all parameters reported for
the two groups of animals was determined using
paired sample student t-test and a p-value of < 0.05
(two tailed) was considered as significant.
RESULTS
Physical observation
Prior to STZ administration, there was no signifi-
cant difference in the average weights of the control
and diabetic groups of rats. By the end of the first
week after diabetes mellitus was experimentally in-
duced, the weights of the diabetic rats were signifi-
cantly reduced despite the increase in food and fluid
intake in these animals. This weight loss continued
for four weeks after STZ administration (Fig. 1). At
the end of the experimental period there was a sig-
nificant decrease in the body weights of the diabetic
rats when compared to the control rats (Table 1). The
animals manifested alopecia (loss of hair on the head)
(Fig. 2) and polyurea shown by marked wetness of
the ventral body surface of the animals.
Changes in blood glucose level
Prior to STZ administration, the fasting blood
glucose levels did not differ significantly between
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the control and diabetic groups of rats. The blood
glucose levels gradually increased during the five-
day period of STZ administration. One week after
administration of STZ, the blood glucose level was
significantly higher in the group-B rats. The blood
glucose level of these rats remained elevated over
a period of four weeks (Fig. 3). Control rats treated
with citrate buffer maintained a normal blood glu-
cose level throughout the period of the experiment.
Changes in weight of left ventricle
aorta and pulmonary trunk
The mean weights of the heart and LV were signif-
icantly higher in the control rats when compared with
STZ treated rats. In addition, the relative ratio of the
left ventricle to the weight of the heart expressed as
a percentage was significantly higher in the control
group of rats when compared to the diabetic rats.
However, there was no significant difference in the
weights of the aorta and pulmonary trunk of the con-
trol and the diabetic groups of rats (Table 2).Figure 2. Photographs of control (A) and diabetic (B) rats.
Figure 1. Weekly changes in the body weights of control and dia-
betic rats.
Figure 3. Weekly changes in the blood glucose levels of control
and diabetic rats.
Table 1. Mean values of the body weight and blood
glucose level of control and diabetic rats after strepto-
zotocin administration
Group Body weight Blood glucose
[g] level [mmol/L]
Group A (initial) 206.64 ± 9.805a 3.59 ± 0.150a
Group A + citrate buffer 204.28 ± 8.307a 3.66 ± 0.200a
Group B (initial) 202.26 ± 6.856a 3.33 ± 0.176a
Group B + streptozotocin 171.28 ± 5.143b 24.17 ± 2.555b
a, b within column signifies that means with different letters differs significantly
at p < 0.05 (two tailed T-test) while means with the same letters does not differ
significantly at p < 0.05 (two tailed T-test)
Table 2. Mean value of weights of the left ventricle, aorta and pulmonary trunk in control and diabetic rats
Wet heart Wet LV Relative heart Aorta weight Pulmonary
weight [g] weight [g] weight (%) [g] trunk weight [g]
Control 0.8723 ± 0.0378 0.2624 ± 0.0341 0.3437 ± 0.0204 29.6835 ± 3.3140 0.1270 ± 0.0383 0.0218 ± 0.0020
Diabetic 0.6053 ± 0.0382 * 0.1302 ± 0.0109* 0.4229 ± 0.0270* 21.8229 ± 1.9166* 0.1162 ± 0.0126 0.0172 ± 0.0084
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Morphological observations
Histological observation of the LV, aorta, and pul-
monary trunk in the two experimental groups revealed
that there was an alteration in the cytoarchitecture of
the STZ treated sections as compared with the con-
trol. The myocardium in the control section presented
well-organized myofibrils with long cylindrical cells
with a centrally placed nucleus as opposed to the de-
rangement of myofibrils and scarce cellular compo-
nents observed in the STZ treated sections. Distribu-
tion of elastic and collagen fibres in the wall of the
aorta, pulmonary trunk, and LV was very scarce in the
diabetic group when compared to the control group.
The distribution of elastic (EL) and collagen (CO) fibres
in the wall of the heart and blood vessels was evident
by the high staining intensities of Verhoeff stain and
van-Gieson’s stain, as shown in Figures 4, 5, and 6.
The tunica intima of the aorta and pulmonary trunk
were significantly thicker in the diabetic rats than in
normal rats.
Morphometric analysis
The results of the morphometric analysis re-
vealed that the luminal diameter of the LV, aorta,
and pulmonary trunk were significantly reduced in
the diabetic group when compared to the control
group, and the wall of these cardiovascular struc-
tures was significantly thicker in the diabetic group
than in the control group (Table 3). The tunica inti-
ma of the aorta and pulmonary trunk were signifi-
cantly thicker in the diabetic group than in the con-
trol group (Table 4). This signifies gradual deposi-
tion of atherosclerotic plaques in the intima of these
vessels. However, there was no significant difference
between the tunica media and adventitia of the con-
trol rats and that of diabetic rats.
Figure 4. Transverse section of the left ventricle of the control
and diabetic rats stained with H & E (A and B, respectively) and
Verhoeff-van Gieson stain (C and D, respectively). Note the distri-
bution of the cardiac muscle cells in A and B (black arrow); note
also the distribution of elastic (EL) and collagen (CO) fibres in
C and D. Bar = 9.09 mm.
Figure 6. Transverse section of the pulmonary trunk of the con-
trol and diabetic rats stained with H & E (A and B, respectively)
and Verhoeff-van Gieson stain (C and D, respectively). Note the
tunica intima (TI), tunica media (TM), and tunica adventitia (TA)
of the wall of the pulmonary trunk in A and B; note also the distri-
bution of elastic (EL) and collagen (CO) fibres in C and D. There is
evidence of lipid deposits (LI) in the tunica intima of the diabetic
rats, as shown in D; LU — lumen; Bar = 9.09 mm.
Figure 5. Transverse section of the aorta of the control and dia-
betic rats stained with H & E (A and B, respectively) and Verhoeff-
-van Gieson stain (C and D, respectively). Note the tunica intima
(TI), tunica media (TM), and tunica adventitia (TA) of the wall of
aorta in A and B; note also the distribution of elastic (EL) and
collagen (CO) fibres in C and D; LU — lumen; Bar = 9.09 mm.
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DISCUSSION
Despite the dramatic improvements in diagnos-
tic procedures and treatment of diabetic patients,
cardiovascular complications are still implicated in
the death of these patients [5]. Consequently, the
study of heart disease in diabetic patients is of great
clinical importance. Dyslipidaemia, a primary risk
factor for the development of atherosclerosis in
diabetic patients, has been reported to impair aor-
tic elastic properties (aortic distensibility), which is
an important determinant of left ventricular func-
tion and coronary blood flow [29]. The histopatho-
logic and morphometric results of this study show
that the tunica intima of the aorta and pulmonary
trunk are significantly thicker in diabetic rats than
in normal rats. This may be due to deposition of
lipid droplets in these vessels to form atherosclerot-
ic plaques. The distribution of elastic and collagen
fibres in the wall of the aorta, pulmonary trunk, and
left ventricle is very scarce in the diabetic rats when
compared to normal rats, leading to a reduction in
the elasticity of these blood vessels. This, together
with the reduction in the luminal diameter of these
vessels, may lead to hypertension in these animals.
Some of the studies in the literature show that the
left ventricle is seriously affected by diabetes, where-
as some of the others demonstrate that the RV is
more severely affected. In most previous studies, the
RV was not even evaluated, partly because only the
left ventricle was subject to the primary haemody-
namic overload, and the pathological processes were
expected primarily to involve the left ventricle. Study
of the mechanisms of biventricular pathology may
provide insight into the pathogenesis of ventricular
damage and subsequent heart failure. Diabetes has
been shown to alter the activities of antioxidant
enzymes in the heart [15, 19, 31, 32], which is
a well-known implication of increased ROS generation.
Researchers have reported increased angiotensin II
levels in diabetic hearts [11, 23, 30]. An important
result of elevated angiotensin II is promoted activa-
tion of NADPH-oxidase, which is a major source of
ROS [4, 7, 14, 22]. G6PD and 6PGD activities were
found to be increased in diabetic hearts, and these
are probably due to increased NADPH production,
a substrate of NADPH oxidases. The activities of an-
tioxidant enzymes GR, GSH-Px, and CAT also in-
creased in diabetic hearts, and AT1 receptor blocker
candesartan-cilexetil normalized their activities sig-
nificantly. Recent findings [34] that showed signifi-
cant reduction of TBARS levels in diabetic hearts af-
ter candesartan treatment support this proposal
and, consequently, our hypothesis, which attributes
a protective role to AT1 receptor blockage against
oxidative stress induced by diabetes.
Our findings suggest that diebetes mellitus caus-
es some alterations that may contribute to the devel-
opment of cardiac and cardiovascular disease in dia-
betes. There is a reduction in the elastic and collagen
fibres in diabetic hearts (especially the left ventricle),
Table 3. Lumen diameter, wall thickness and wall to lumen ratio of left ventricle (LV), aorta and pulmonary trunk (PT) in
control and diabetic rats
LV wall LV lumen LV wall: Aorta wall Aorta lumen Aorta wall: PT wall PT lumen PT wall:
thickness diameter lumen thickness diameter lumen thickness diameter lumen
[mm] [mm] ratio [mm] [mm] ratio [mm] [mm] ratio
Control 529.10 ± 2841.23 ± 0.1875 ± 151.75 ± 1192.53 ± 0.129 ± 63.35 ± 749.26 ± 0.085 ±
± 28.096 ± 104.44 ± 0.013 ± 9.765 ± 55.341 ± 0.009 ± 5.415 ± 15.316 ± 0.007
Diabetic 692.96 ± 1910.18 ± 0.3637 ± 217.58 ± 928.33 ± 0.234 ± 97.61 ± 555.88 ± 0.175 ±
± 20.768* ± 45.06* ± 0.011* ± 12.773* ± 17.860* ± 0.012* ± 4.738* ± 10.250*  ± 0.007*
*Values are significantly different from control at p < 0.05 (two tailed T-test)
Table 4. Thicknesses of the tunica intima, media and adventitia of the aorta and pulmonary trunk in control and diabetic rats
Thickness of Thickness of Thickness of Thickness of Thickness of Thickness of
aorta intima aorta media adventitia pulmonary trunk pulmonary trunk pulmonary trunk
[mm] [mm] [mm] intima [mm] media [mm] adventitia [mm]
Control 3.62 ± 0.353 96.52 ± 11.501 45.52 ± 3.840 3.22 ± 0.244 45.15 ± 2.602 19.80 ± 1.222
Diabetes 14.59 ± 1.189* 104.90 ± 9.050 41.280 ± 2.595 11.307 ± 0.863* 40.16 ± 2.628 17.16 ± 0.719
*Values are significantly different from control at p < 0.05 (two tailed T-test)
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aorta, and pulmonary trunk. In previously published
papers [8, 21], the effect of diabetes on the hearts of
animals and/or humans that were diabetic for long
periods of time (mostly from 2 months to 10 years)
have been investigated [24, 25]. The present study
demonstrates that even a relatively short term
(4 weeks) of diabetes induces significant effects, as
mentioned above, on the left ventricular myocardium,
aorta, and pulmonary trunk in rats.
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